comparemela.com

Latest Breaking News On - Department of research evaluation - Page 4 : comparemela.com

Pneumonia vaccine may affect course of COVID-19

Share this article Share this article PASADENA, Calif., March 10, 2021 /PRNewswire/  A Kaiser Permanente study showed that one type of pneumonia vaccine, the PCV13 vaccine, may affect the course of COVID-19 for some older adult patients. The study was published in The Journal of Infectious Diseases. Kaiser Permanente members who received the PCV13 vaccine appeared to be diagnosed with COVID-19 less often, and when they were, they seemed to have less severe outcomes, overall, said the senior author, Sara Y. Tartof, PhD, MPH, a scientist with the Kaiser Permanente Southern California Department of Research & Evaluation. One of the most interesting aspects of our findings was that the patients who received PCV13 received some protection against COVID-19, while those who received PPSV23, another pneumococcal vaccine, did not.

Assessment of Neonatal Abstinence Syndrome Surveillance — Pennsylvania, 2019

What is already known about this topic? Neonatal abstinence syndrome (NAS) has increased as part of the U.S. opioid crisis, but no national NAS surveillance system exists, and data about the accuracy of state-based surveillance are limited. What is added by this report? Among infants with confirmed NAS at five Pennsylvania hospitals, ICD-10-CM code P96.1 was assigned to 71% of those who were reported to the NAS surveillance system and 78% of those who were not reported to surveillance. What are the implications for public health practice? Accurate NAS surveillance, which is necessary to monitor changes and regional differences in incidence and assist with planning for needed services, includes a combination of diagnosis code assessment and focused medical record review.

Chest pain risk assessment may reduce treatment disparities

 E-Mail The use of a standardized tool for assessing the risk of serious outcomes in patients with chest pain was associated with women at high risk receiving comparable care to men, according to new research published in the Annals of Emergency Medicine. Care received by women at low and intermediate risk was consistent with current clinical recommendations. Men received more stress testing and were more likely to be hospitalized than women. The researchers goal in this study was to look at gender disparities after developing and implementing a standardized approach to cardiac care for patients in 2016, using the HEART score. The HEART score, which stands for history, electrocardiogram, age, risk factors, and troponin level, is used to determine risk for adults with suspected acute coronary syndrome and based on that risk informs clinical decisions and standard care recommendations.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.